USPTO serial 86834749
KLUS PHARMA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 13, 2018
- Examiner
- BURNS, ELLEN
- Law office
- Historical data usage
What this means
Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary. Calendar the 10-year Section 8 and 9 combined renewal.
Need help with KLUS PHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Sichuan Kelun Pharmaceutical Co., Ltd.
Chengdu, Sichuan, CN
Other trademarks owned by Sichuan Kelun Pharmaceutical Co., Ltd.
Sichuan Kelun Pharmaceutical Co., Ltd.
Chengdu, Sichuan, CN
Other trademarks owned by Sichuan Kelun Pharmaceutical Co., Ltd.
Sichuan Kelun Pharmaceutical Co., Ltd.
Chengdu, Sichuan, CN
Other trademarks owned by Sichuan Kelun Pharmaceutical Co., Ltd.
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
SICHUAN, CN
Other trademarks owned by SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Amy C. Ziegler
Amy C. Ziegler GREER, BURNS & CRAIN, LTD.200 W. Madison St.Suite 2100CHICAGO, IL 60606Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Anaesthetics; antiseptics; Media for bacteriological cultures; Diagnostic media for bacteriological cultures; Analgesic preparations; Pharmaceutical preparations, namely, anticoagulants; collyrium; Dietary fiber for treating constipation; analgesics; Antiallergic medicines; Preparations for treating colds; fungicides; Tranquilizers; germicides; sedatives; Hyaluronic acid for pharmaceutical purposes; Veterinary preparations, namely, antioxidants; Biological preparations for the treatment of cancer; Opium alkaloid preparations; Styptic pencils; medical preparations for slimming purposes; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer; Medicines for dental purposes; Medicines for intestinal disorders; Bouillons for bacteriological cultures; Bacterial and bacteriological preparations for medical or veterinary purposes; diagnostic preparations for medical purposes; All purpose disinfectants | ACTIVE | Dec 28, 2017 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Sichuan Kelun Pharmaceutical Co., Ltd.
- Other trademarks owned by Sichuan Kelun Pharmaceutical Co., Ltd.
- Other trademarks owned by Sichuan Kelun Pharmaceutical Co., Ltd.
- Other trademarks owned by SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
- Other trademarks in Class 005
- Similar marks named KLUS PHARMA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 15, 2025 | NAS8 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | — |
| Mar 15, 2025 | 8.OK | REGISTERED - SEC. 8 (6-YR) ACCEPTED | The USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline. |
| Mar 15, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 24, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 24, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Sep 24, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 24, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 25, 2024 | ES8R | TEAS SECTION 8 RECEIVED | — |
| Mar 13, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jan 19, 2022 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Mar 13, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 6, 2018 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Feb 3, 2018 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jan 24, 2018 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jan 22, 2018 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jan 11, 2018 | IUAF | USE AMENDMENT FILED | — |
| Jan 11, 2018 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Aug 9, 2017 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 7, 2017 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 7, 2017 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 7, 2017 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 7, 2017 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 13, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 13, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 23, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 4, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 28, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 6, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 6, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 2, 2016 | ALIE | ASSIGNED TO LIE | — |
| Sep 23, 2016 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 23, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 25, 2016 | GEAN | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Mar 25, 2016 | GEAP | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Mar 25, 2016 | EPEN | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY | — |
| Mar 25, 2016 | CPEA | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | — |
| Mar 17, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 4, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 3, 2015 | NWAP | NEW APPLICATION ENTERED | — |